BBH Stock UPDATES Biotech ETF Market Vectors (BBH) 113.38 10/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biotech ETF Market Vectors (BBH) 113.38 $BBH

The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, Market Vectors Biotech ETF and PowerShares Dynamic Biotechnology & Genome Portfolio- GENOME
PR Newswire - Fri Oct 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report) and PowerShares Dynamic Biotechnology & Genome Portfolio - GENOME (AMEX BE-Free Report).
FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), BBH: 113.38 (-1.17)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 49.36 (-0.23), FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), BBH: 113.38 (-1.17), IBB: 290.63 (-3.32)

Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 10, 11:00AM CDT
A look at biotech ETFs following some weakness in one of the key companies in the space, Gilead (GILD).
PBE: 49.36 (-0.23), GILD: 110.72 (-2.73), BBH: 113.38 (-1.17), IBB: 290.63 (-3.32)

Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
BIIB: 315.06 (-2.97), PBE: 49.36 (-0.23), GILD: 110.72 (-2.73), FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17)

After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
BIIB: 315.06 (-2.97), PBE: 49.36 (-0.23), GILD: 110.72 (-2.73), FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17)

Last Week's ETF Highlights: MLP and Biotech Funds Soar, Volatility Sinks - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 20, 7:00AM CDT
Which ETFs led the market higher and lower last week?
ZROZ: 109.01 (+0.55), KMI: 38.33 (-0.84), VXX: 31.02 (+0.52), FCG: 15.15 (+0.15), BBH: 113.38 (-1.17), MLPI: 43.87 (unch), CVOL: 1.21 (+0.01)

Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.
GILD: 110.72 (-2.73), PJP: 67.01 (-0.06), AMGN: 158.88 (+1.69), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17), CELG: 105.14 (-0.56)

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.
SOCL: 18.55 (-0.43), VB: 113.43 (-0.22), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17), IWM: 113.90 (-0.27)

The Zacks Analyst Blog Highlights:Vertex Pharmaceuticals, Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, First Trust NYSE Arca Biotechnology Index Fund, PowerShares Dynamic Biotechnology & Genome Portfolio and SPDR S&P Biotech ETF
PR Newswire - Thu Jun 26, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Vertex Pharmaceuticals (Nasdaq:VRTX-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report), iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), PowerShares Dynamic Biotechnology & Genome Portfolio (AMEX BE-Free Report) and SPDR S&P Biotech ETF (AMEX:XBI-Free Report).
PBE: 49.36 (-0.23), FBT: 97.68 (-0.61), BBH: 113.38 (-1.17)

Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
PBE: 49.36 (-0.23), FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17)

Biotech HOLDRs Trust Shares Down 10.5% Since SmarTrend's Sell Call (BBH)
Comtex SmarTrend(R) - Mon Mar 31, 9:27AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 3 weeks, Biotech HOLDRs Trust has returned 10.52% as of today's recent price of $89.55.
BBH: 113.38 (-1.17)

3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 24, 1:00PM CDT
The terrible trading in the biotech stock world sent these ETFs into deep red in Friday session.
BIIB: 315.06 (-2.97), GILD: 110.72 (-2.73), XBI: 169.62 (-1.89), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)

Nasdaq Glitch Hits ETF Market Too - ETF News And Commentary
Eric Dutram - ZACKS - Fri Aug 23, 10:00AM CDT
More than 100 ETFs trade on the Nasdaq, including several popular funds, leaving many investors in the dark during Thursday's session.
QQQ: 99.81 (-0.37), IAI: 39.55 (+0.10), SQQQ: 34.02 (+0.36), IBB: 290.63 (-3.32), BBH: 113.38 (-1.17), TQQQ: 88.00 (-1.07), NDAQ: 42.43 (+0.61)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Fluoride Market to Hit $3.3B by 2031

Updated Category News Views 33

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Continue Reading
MGS Extends Engagement for BECI Power Line Project

Updated Category News Views 77

The power game isn't always about flipping switches, my friends. With Midcontinent Grid Solutions (MGS), we're seeing another round of crowd-pleasing playacting as they pump the brakes on the BECI Project. New timeline, new promises—same old story. Investors, environmentalists, and citizens alike are watching this one unfold with a glass of iced tea and crossed fingers....

Continue Reading
Etavopivat Aims to Tackle Sickle Cell Crisis Head-On

Updated Category News Views 53

Diving headfirst into the world of sickle cell disease, Novo Nordisk has just thrown its hat in the ring with etavopivat. Now, anyone who's been following the biotech dance knows this ain't no small feat. This investigational therapy is poised to shake things up, offering a new lifeline for those wrestling with this debilitating condition. And leaping from the Phase 3...

Continue Reading
Chicken Salad Chick Expands in PA with Collegeville Launch

Updated Category News Views 130

Chicken Salad Chick Expands Further into Pennsylvania Hot off the grill! If you're in Pennsylvania, especially around Collegeville, you might want to perk up. Chicken Salad Chick, that quirky Southern-style restaurant chain that's all about—you guessed it—chicken salad, is doubling down on its presence in the state. Come November 18, chicken enthusiasts can graze on...

Continue Reading
Gates Unveils ThermalCool 2100SS: A Game-Changer?

Updated Category News Views 65

Breaking into Unseen Data Center Challenges When you cram more computing power into a single rack than ever before, every single part better pull its weight. Gates Industrial Corporation Ltd. (NYSE: GTES) just threw down the gauntlet with their new toy: the ThermalCool™ 2100SS Pump. Number crunching ain't just about the processor or memory anymore. If the cooling system...

Continue Reading
CytoSorbents Hits Financial Milestone in Q3 2026

Updated Category News Views 52

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

Continue Reading
AiPrise Token Sharing Streamlines Compliance Tasks

Updated Category News Views 125

Streamlining the Redundant Chore of Compliance Now, here's something with teeth. AiPrise rolls out its Token Sharing infrastructure, a crafty solution to a common hassle—duplicated compliance work. It's a game changer for financial institutions that find themselves drowning in a sea of repetitive verification tasks. The notion of sharing verified customer data among...

Continue Reading
Brookdale Ready to Share Insights at Stephens Conference

Updated Category News Views 59

Navigating Through the Senior Living Space Oh, the world of senior living—never a dull moment and full of its own nuances. Brookdale Senior Living Inc., right in the thick of it, is prepping to lay it all out at the Stephens Annual Investment Conference this year. Now, they're taking the stage in Nashville on November 19, brimmed with numbers, charts, and possibly a...

Continue Reading
Hollyland Powers APEC 2026 with Wireless Solutions

Updated Category News Views 56

APEC 2026 Finds a Partner in Hollyland Here's a nugget for ya: Hollyland, the pride of Shenzhen in wireless audio and video solutions, is stepping into the big leagues by becoming an official sponsor for the APEC 2026 meetings. Now that's quite the homecoming parade! Given the bustling vibes of a global conference, Hollyland’s gear will play a starring role in keeping...

Continue Reading
Ani Huang: NAHR Fellow Elevates HR Leadership Standards

Updated Category News Views 19

Spotlight on Ani Huang's HR Leadership In a world where corporate strategies and workforce dynamics continually evolve, Ani Huang's ascent to Fellow of the National Academy of Human Resources (NAHR) signals a pivotal recognition. It's not just another pat on the back; it's a validation of a career steered by determination, expertise, and a knack for navigating the tangled...

Continue Reading

Top 5 Most Recently Viewed Articles

Carnival Corporation Reports Anticipated Q3 Earnings Changes

Updated Category News Views 99

Carnival Corporation Prepares for Significant Q3 Earnings Carnival Corporation CCL is gearing up to release its earnings results for the third quarter soon. Investors eagerly await this report, particularly as analysts have revised their expectations. Analyst Forecasts for Carnival's Performance Analysts are predicting that the Miami-based cruise line will reveal earnings...

Continue Reading
Exciting Developments in Global Wellness for the Upcoming Summit

Updated Category News Views 255

Global Wellness Summit: A New Era of Collaboration The Global Wellness Summit (GWS) is gearing up for its 19th annual conference, set to redefine the landscape of the wellness industry. This conference will take place in the opulent Emirates Palace Mandarin Oriental, where the leaders of the global wellness economy will converge. Strategic Partnerships in Focus The event,...

Continue Reading
Chery's HIMLA Series Launch Transforms Pickup Landscape

Updated Category News Views 427

Chery Introduces the All-New HIMLA Series At the renowned Shanghai Auto Show, Chery took a significant step forward by unveiling its all-new pickup series—HIMLA. This launch represents a pivotal moment in the automotive horizon for the Chinese manufacturer, aligning with the growing global interest in robust pickup vehicles. With HIMLA, Chery isn’t just adding another...

Continue Reading
Aicuris Reaches Milestone with Pritelivir Enrollment for HSV Trial

Updated Category News Views 412

Aicuris Advances Pritelivir Enrollment for HSV Treatment Today, Aicuris Anti-infective Cures AG announced they have successfully completed patient enrollment in their pivotal Phase 3 trial, known as PRIOH-1, which focuses on the promising treatment, pritelivir, aimed at combating refractory herpes simplex virus (HSV) infections in immunocompromised patients. Pritelivir...

Continue Reading
Pan African Film Fund Seeks $1B for Creative Industries

Updated Category News Views 52

Revolutionizing African Storytelling on a Global Scale Every so often, a bold move shakes an industry to its core, and that's exactly what's happening in the African creative sectors. The African Export-Import Bank (Afreximbank) and the Fund for Export Development in Africa (FEDA) have announced a partnership with One Street Studios as co-general partners of the Pan...

Continue Reading